Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent
- 30 September 1979
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 44 (3), 526-532
- https://doi.org/10.1016/0002-9149(79)90407-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Canine electrophysiology of encainide, a new antiarrhythmic drugThe American Journal of Cardiology, 1979
- Human electropharmacology of tocainide, a lidocaine congenerThe American Journal of Cardiology, 1978
- New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamilThe American Journal of Cardiology, 1978
- Clinical electrophysiologic effects of tocainide.Circulation, 1978
- Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part BAmerican Heart Journal, 1975
- Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. AAmerican Heart Journal, 1975
- The electrophysiology of propranolol in manAmerican Heart Journal, 1974
- The electrophysiological effects of intramuscular quinidine on the atrioventricular conducting system in manAmerican Heart Journal, 1974
- Electrophysiological evaluation of disopyramide in manAmerican Heart Journal, 1973
- Lysergic acid and quinidine analogs. 2-(o-Acylaminophenethyl)piperidinesJournal of Medicinal Chemistry, 1973